Corporate Whistleblower Center Expands Their Initiative Focused On Big Pharma Paying Off MD's In Any Way Because The Reward Potential Can Be In The Millions

Share Article

The Corporate Whistleblower Center is urging pharmaceutical representatives, or medical doctors to call them at 866-714-6466, about what could be multi million dollar rewards, if they have well documented proof a drug company is providing kickbacks to physicians. The Corporate Whistleblower Center says, "When the DOJ jumps into a case involving a major pharmaceutical company, with the allegation being kickbacks, drug representatives, or MD's should strongly consider calling us about more information about federal whistleblower reward programs, and the best possible attorneys to help." http://CorporateWhistleblowerCenter.Com

News Image
As alleged, Novartis corrupted the prescription drug dispensing process with multi-million dollar ‘incentive programs’ that targeted doctors who, in exchange for illegal kickbacks, steered patients toward its drugs

The Corporate Whistleblower Center says, "Pharmaceutical representatives, or physicians should pay attention when the United States Department of Justice jumps into a whistleblower case involving medical doctors, a big drug company, and kickbacks, because it is a signal someone probably is going to get a huge whistleblower reward. Because of this development we are going to expand all of our big pharma, and medical doctor kickback inititiatives. While the Justice Department has not yet declared a settlement, the fact that they jumped into this alleged misconduct is a very big deal, and we want to help potential whistleblowers cash in on their information, if they have proof of drug companies paying off doctors, to prescribe more drugs."

According to a April 16th 2013 national press release from the Justice Department, "As alleged, Novartis corrupted the prescription drug dispensing process with multi-million dollar ‘incentive programs’ that targeted doctors who, in exchange for illegal kickbacks, steered patients toward its drugs." The Corporate Whistleblower Center is urging pharmaceutical representatives, or for that matter medical doctors to call them, if they possess information related to big drug companies paying off doctors with kickbacks. For more information potential whistleblowers are encouraged to contact the Corporate Whistleblower Center anytime at 866-714-6466.

Simple rules for a whistleblower from the Corporate Whistle Blower Center:

  • Do not go to the government first, if you are a major whistleblower. The Corporate Whistleblower Center says, "Major whistleblowers frequently go to the federal government thinking they will help. It's a huge mistake. Frequently government officials could care less, or they are incompetent."
  • Do not go to the news media with your whistleblower information. Public revelation of a whistleblower's information could destroy any prospect for a reward.
  • Do not try to force a government contractor, or corporation to come clean to the government about their wrong doing. The Corporate Whistleblower Center says, "Fraud is so rampant among federal contractors, that any suggestion of exposure might result in an instant job termination, or harassment of the whistleblower. We say, come to us first, tell us what type of information you have, and if we think its sufficient, we will help find the right law firms, to assist in advancing your information

Any type of insider, or employee, who possesses significant proof of their employer, or a private contractor is fleecing the federal government out of millions of dollars is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466, or they can contact the group via their web site at http://CorporateWhistleblowerCenter.Com

For attribution purposes please read the United States Department of Justice's press release titled: United States Files Complaint Against Novartis Pharmaceuticals Corp. for Allegedly Paying Kickbacks to Doctors in Exchange for Prescribing Its Drugs, dated April 26th 2013: http://www.justice.gov/opa/pr/2013/April/13-civ-481.html

Case Number Information: The lawsuit is United States ex rel. Bilotta v. Novartis Pharmaceuticals Corporation et al., No. 11-cv-0071 (S.D.N.Y.).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

M Thomas Martin
Visit website

Media